Wasn’t this an approved medicine?

What happened to Geref?

A test came first

December 1990 brought approval for a test of the gland’s ability to release growth hormone.

A children’s treatment followed

In September 1997, sermorelin gained approval for children whose hormone shortage was limiting growth.

The approvals ended

At the maker’s request, the Food and Drug Administration (FDA) withdrew both approvals, effective June 18, 2009.

A later finding needs context

In March 2013, the FDA said Geref’s sale had ended for reasons other than being unsafe or failing to work.

That decision concerned the old product. It did not approve medicine made for you now.

Can a pharmacy prepare it now?

Sermorelin acetate names the specific chemical version used in Geref, the old approved medicine. Acetate is part of that ingredient’s name, rather than a second medicine.

A pharmacy with a state licence may prepare this version for one patient under the federal rules reviewed September 28, 2026.

It needs a valid prescription naming you. The ingredient must be made by an FDA-registered business and come with a certificate showing its test results. Applicable pharmacy quality standards and the other federal conditions still apply; state rules may add limits.

This conclusion applies general FDA rules to sermorelin; no FDA document found in the source review gives permission for it by name.

It cannot settle whether a particular pharmacy’s offer meets the law. Ask the pharmacist to explain the checks above, then ask your state pharmacy board about that pharmacy and medicine.

A preparation made this way still has no FDA product approval.

What does that mean for an adult?

Sermorelin never had an approval for adult treatment, according to the records reviewed on September 28, 2026.

• What condition is the prescription intended to address?
• What supports this use in adults, rather than its old use in children?